GUIDED THERAPEUTICS INC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Guided Therapeutics Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Guided Therapeutics Inc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 54.1K shares.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 54.1K -51M Jun 30, 2024 10-Q 2024-08-14
Q1 2024 55.6K -50.8M Mar 31, 2024 10-Q 2024-05-14
Q4 2023 54.1K -48.5M Dec 31, 2023 10-Q 2024-08-14
Q3 2023 52M* +24.5M Sep 30, 2023 10-Q 2023-11-13
Q2 2023 51M* +23.4M Jun 30, 2023 10-Q 2023-08-10
Q1 2023 50.8M* +28.5M Mar 31, 2023 10-Q 2023-05-15
Q4 2022 48.6M* +34.9M Dec 31, 2022 10-K 2024-03-28
Q3 2022 27.6M +14M +103% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 27.6M +27.6M +207338% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 22.3M +22.3M +169217% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 13.7M +535K +4.07% Dec 31, 2021 10-K 2023-03-30
Q3 2021 13.6M +13.6M +115557% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 13.3K +532 +4.17% Jun 30, 2021 10-Q 2021-08-18
Q1 2021 13.2K +1.42K +12% Mar 31, 2021 10-Q/A 2021-08-18
Q4 2020 13.1M +13.1M +395742% Dec 31, 2020 10-K 2022-03-30
Q3 2020 11.8K +9.1K +341% Sep 30, 2020 10-Q/A 2020-11-05
Q2 2020 12.8K +9.45K +285% Jun 30, 2020 10-Q 2020-08-20
Q1 2020 11.8K +8.45K +254% Mar 31, 2020 10-Q 2020-07-07
Q4 2019 3.32K +650 +24.4% Dec 31, 2019 10-K 2021-04-07
Q3 2019 2.67K -382K -99.3% Sep 30, 2019 10-Q 2020-03-09
Q2 2019 3.32K -265K -98.8% Jun 30, 2019 10-Q 2020-02-11
Q1 2019 3.32K -135K -97.6% Mar 31, 2019 10-Q 2019-07-11
Q4 2018 2.67K -59.3K -95.7% Dec 31, 2018 10-K 2020-04-20
Q3 2018 384K +375K +3935% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 268K +266K +10467% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 138K +137K +9593% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 62K +61.3K +9161% Dec 31, 2017 10-K 2019-05-08
Q3 2017 9.52K +9.13K +2342% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 2.54K -82.4K -97% Jun 30, 2017 10-Q 2017-08-18
Q1 2017 1.43K -3.9K -73.2% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 669 +666 Dec 31, 2016 10-K/A 2018-04-20
Q3 2016 390 -96.5K -99.6% Sep 30, 2016 10-Q 2016-12-05
Q2 2016 85K -11.9K -12.3% Jun 30, 2016 10-Q 2016-08-17
Q1 2016 5.32K -91.6K -94.5% Mar 31, 2016 10-Q 2016-05-19
Q4 2015 3* -96.9K Dec 31, 2015 10-K 2017-03-22
Q3 2015 96.9K -79.3M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 96.9K +21.4K +28.3% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 96.9K +25.1K +35% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 96.9K +26.4K +37.5% Dec 31, 2014 10-K 2016-03-15
Q3 2014 79.4M* +79.3M Sep 30, 2014 10-Q 2014-11-12
Q2 2014 75.5K +9.42K +14.3% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 71.8K +6.28K +9.59% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 70.5K +8.2K +13.2% Dec 31, 2013 10-K 2015-03-25
Q3 2013 66.3K +4.12K +6.62% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 66.1K +9.91K +17.6% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 65.5K +12.8K +24.3% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 62.3K +10.1K +19.3% Dec 31, 2012 10-K 2014-03-26
Q3 2012 62.2K Sep 30, 2012 10-Q 2012-11-13
Q2 2012 56.2K +7.68K +15.8% Jun 30, 2012 10-Q/A 2012-08-24
Q1 2012 52.7K Mar 31, 2012 10-Q 2012-05-14
Q4 2011 52.2K +4.91K +10.4% Dec 31, 2011 10-K 2013-03-27
Q2 2011 48.5K Jun 30, 2011 10-Q 2011-11-14
Q4 2010 47.3K Dec 31, 2010 10-K 2012-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.